Poland Is 'the Place to Be' for College of Medicine Fulbright Scholar
Janusz Suszkiw, PhD, a professor in the
molecular and cellular physiology
department in the College of Medicine, is one of four UC faculty members to receive a Fulbright grant, the U.S. governments prestigious international educational exchange program, for the 200506 academic year.
The Polish-born neuroscientist will do research in his homeland at the Nencki Institute of the Polish Academy of Sciences, Warsaw, and at the Gdansk Medical Academy.
The fact that hes going to Poland, says Suszkiw, who has already done sabbaticals at the
world-renowned Max Planck Institute in Göttingen, Germany, and at the National Institutes of Health in Bethesda, Md., is largely coincidental. His area of research is in the causes of neuronal degeneration, compensatory phenomena and pharmacological interventions to lessen neurodegenerative changes in the brain, whether induced by toxins in the environment lead poisoning in children, for exampleand ageing-related diseases like Alzheimers and Parkinsons.
And for sheer excellence of research in this fieldespecially new discoveries about the role of what are known as the extracellular matrix metalloproteinases in development, neurodegeneration and brain repairPoland is the place to be, he says.
Suszkiw, who came to the United States as a teenager, worked his way through school, earning his undergraduate degree in chemistry and a masters and PhD in biochemistry at George Washington University, followed by postdoctoral training in neurobiology at Cornell.
The son of a physician, Suszkiw says he always wanted to do biomedical research.
I was always of a philosophical bent, he said. As a kid, I wanted to know how the universe worked. But before understanding the universe, you have to try to figure out how the brain works, because thats what interprets the universe.
After being engaged in basic neurobiological studies, a personal experience with the ravages of Alzheimers disease in his mother prompted Suszkiw to switch his research focus to neurodegenerative diseases. Studying the mechanisms of neurodegeneration and brain repair, he says, actually is another way to learn how the normal brain works but, more important, it has the added advantage that it may lead to potential therapeutic applications.
The other UC Fulbright recipients were Vanessa Kay Allen-Brown, associate professor in Educational Studies, who will go to Cairo University; Katharina Gerstenberger, associate professor in German Studies, who toured throughout Germany last summer; and Daniel Oerther, assistant professor of environmental engineering, whose Fulbright will take him to the Manipal Academy of Higher Education in Manipal, India.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.